# Tolerance and Performance of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Brown Spots.

> **NCT05625815** · NA · COMPLETED · sponsor: **Cryonove Pharma** · enrollment: 32 (actual)

## Conditions studied

- Solar Lentigo
- Senile Lentigo
- Post-inflammatory Hyperpigmentation

## Interventions

- **DEVICE:** Prototypes (816-v1 001) to (816-v1 050)
- **DEVICE:** Prototype (816-v1 051) to (816-v1 100)
- **DEVICE:** Prototypes (816-v1 101) to (816-v1 150)
- **DEVICE:** Prototypes (816-v1 151) to (816-v1 200)

## Key facts

- **NCT ID:** NCT05625815
- **Lead sponsor:** Cryonove Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-04-17
- **Primary completion:** 2023-08-07
- **Final completion:** 2023-10-10
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2024-01-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05625815

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05625815, "Tolerance and Performance of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Brown Spots.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05625815. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*